ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BOX Boxhill Tech

0.055
0.00 (0.00%)
17 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Boxhill Tech LSE:BOX London Ordinary Share GB00B1DWH640 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.055 0.04 0.07 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Boxhill Share Discussion Threads

Showing 5001 to 5025 of 6350 messages
Chat Pages: Latest  206  205  204  203  202  201  200  199  198  197  196  195  Older
DateSubjectAuthorDiscuss
06/5/2015
14:10
Think someone just sold alot... shame it was going well
newvest1
06/5/2015
13:20
10 bagger!! Ten Bagger Tuesday Q1: What name do you want to be known as? Paul Wild Q2: What’s the name AND ticker symbol of the company you think is a possible ten bagger? BOX Boxhill Technology Q3: What does the company do? Provides Payment Solutions to FOREX and Casino Companies. The later is a niche business where the company (last announcement) supplied 14 casinos which is currently being extended to 50. Q4: What’s current price AND market capitalisation of the company? 00.001 (Tenth of one pence) GBP 1.5 Milion This has the potential to 10 bag in the next weeks. Q5: Name three reasons why you think this company is a possible ten bagger. 1 Seriously Under Valued and Under the radar. 2 Results Update due in the next two weeks – which will potentially put this company on a PE of 1.5 Times. Conservatively the PE should be multiples of the current level. 3 Box work in a niche sector supplying FOREX and Casinos with payment services. Casino business is a niche and extremely lucrative.
monkey puzzle
06/5/2015
12:43
can you sell some more?
johnyee 7
06/5/2015
12:21
Hey guys..you have me to thank for the share price rise!I sold some this morning b4 the increase..as is my normal luck it goes up! Still have a lot left so happy to hold for the real gains..imho
113mike
06/5/2015
12:15
m- Spot on IMHO....GL S
swizz
06/5/2015
12:13
It could be as simple as investors looking at the interim results and realising how undervalued this stock is.
mostyn
06/5/2015
12:06
Not so sure about news on the way, we have seen trading updates post results last year, so perhaps this year will be the same and it would be good to get a sense of current activity, the other point of note is the Harvey Hadden Sports Complex is due to re-open in a few weeks, so perhaps Soccerdome news is not to far away?.....GL S
swizz
06/5/2015
12:01
Interesting........
monkey puzzle
06/5/2015
11:57
News on the way?
newvest1
06/5/2015
11:52
Bought in this am ;)
bean02
05/5/2015
19:14
The podcast was meant to show a company that could 10 bag. The only thing missing was any real reason why the Boxhill share price could do this. There was plenty of good stuff that could have been taken from the interims - comment on gross margin, comment on likely 2nd half turnover, comment on the control of costs, comment on soccerdome, comment on the likely growth of the e-payments business - all absent. Only good as a teaser to get investors to do some research - and how many really want to do the hard work!
mostyn
05/5/2015
18:55
Mention for BOX on the Podcast, albeit with a number of inaccuracies, but at least they have a small mention, from circa 33.20....GL S
swizz
05/5/2015
14:31
It's surprising that there are still some sellers around. I suppose if one is just a trader it might rate a sale just because it isn't moving much. As an investor why would you sell a growth stock with a likely p/e for 2015 of between 2 and 3. We do need a trading update to enable investors to buy into the story. The company do appear to have a good story to tell so they need to tell it. When there is a specific event or announcement from the company that alerts the market to this stock, it could easily go up 50%+ in a day. It's just a case of when that day might be.
mostyn
01/5/2015
19:45
Mostyn - many thanks. Bought more today on the dip. Looking forward to the trading update.
smudgedan
01/5/2015
19:38
113m, indeed lol

m, agreed and let's hope so.....GL S

swizz
01/5/2015
19:33
swizz,

When the market picks up on this company there will be a lot more buying. I have worked out the likely full year figures, on what is known now, and this seems amazingly cheap. I expected the shares to rise on the results but at least I have been able to add at this level. Give it a few weeks and 0.12p may be a distant memory.

mostyn
01/5/2015
17:46
or Tuesday
113mike
01/5/2015
17:45
No wonder WINS were on the move just before close, delayed buy for 8.3M ticks through, bodes well for Monday......have a great weekend everyone.......GL S
swizz
01/5/2015
07:57
smudgedan,

"We really do need a trading update giving the current status"

I spoke to the company yesterday. They are aware of this, and my guess is that we will see something fairly soon. We didn't discuss anything that isn't already known. I wanted to discuss one or two assumptions I had made based on the results and was able to do this. I am very optimistic going forward, and am still of the view that in time the share price will do very well.

mostyn
30/4/2015
18:52
We really do need a trading update giving the current status of the payment processing and casino businesses. We know they are growing from the revenue predictions but I can't see the harm in giving us some more specifics.

There is clearly a good story to be told, so please can the company get on with telling it.

smudgedan
30/4/2015
17:08
m, it is surprising that no-one has picked up on Boxhill, but then again it is a rarity to have a company with a real business and making profits on AIM!, agreed on the balance sheet thoughts, it was also good to see some of the profit being utilised to reduce the bank borrowing significantly,......GL S
swizz
30/4/2015
16:52
I'm very surprised that no commentators/share tipsters have picked up on Boxhill.

They have returned to a very good profit.
The balance sheet looks much better.
Turnover for the year should be at least double last year (stated in the results).
The prospective p/e for this year is less than 3.
The benefits of the soccer side reopening are still to come.

This is a profitable and expanding AIM company - somewhat of a rarity.

The end result - there is very little interest and the share price is virtually no better than before the results.

I will be holding these for the long term, and will be amazed if they are not a multiple of the current price in 12 months time.

mostyn
29/4/2015
20:05
Interesting to note our Chair has taken on a new advisory role with Naia Ltd......GL S

Link....



Naia Limited, an international drug development company with an initial portfolio of innovative, clinical stage compounds for short bowel syndrome, NASH and Type 2 diabetes, today announced three additions to its business advisory board. The new members are Edmund Pezalla, M.D., MPH, vice president and national medical director for pharmaceutical policy and strategy at Aetna, Hoyoung Huh, M.D., Ph.D., chairman of the board of directors of Geron Corporation and Cytomx Therapeutics, Inc., and Lord Edward (Tim) Razzall, Commander of the Order of the British Empire (CBE), partner at RT Associates, and leading member of the Liberal-Democratic Party (U.K.).

The three new business advisory board members have joined existing members, Jorge Puente, M.D., chairman of Naia’s business advisory board, co-founder and managing partner at Pleasanton Pharma Ventures, and prior regional president, Asia Pacific and Canada, of Pfizer’s Oncology Business Unit, and Robert Williamson, CEO of PharmAkea and prior board member of Pharmasset. The company’s business advisory board plays a central role in Naia’s strategy and differentiation as its five board members are diverse, high-profile individuals whose expertise and backgrounds actively guide Naia’s strategy and operating philosophy.

“We welcome Drs. Pezalla and Huh and Lord Razzall to our business advisory board,” said Dr. Puente. “The fact that these distinguished individuals with differing domain experiences and insights decided to join our board, underscores the differentiation and appeal of Naia’s business model. Under the leadership of an experienced management team, Naia is quickly building a strong portfolio of exciting therapeutic products.”

Lord Razzall, CBE, a solicitor in the U.K., has more than 35 years of corporate finance experience, particularly in multinational and cross border transactions. He is currently a partner at RT Associates, a business advisory firm for growth companies in a variety of industries including healthcare. He is also chairman of the payment systems provider Boxhill Technologies PLC and director of the finance company Just Loans PLC. Lord Razzall has had a long political career in the U.K. Currently, he is the co-chairman of the Parliamentary Committee for Treasury matters. Previously, he held the post of Liberal Democrat Spokesperson for Trade and Industry/Business, Enterprise and Regulatory Reform. He was treasurer of the Liberal/Liberal Democratic Party after which he chaired the Liberal Democrats General Election Campaigns of 2001 and 2005. Earlier in his career, he served as partner and chief executive at Frere Cholmeley Bischcoff.

About Naia Limited

Naia Limited is employing a creative business model for global drug development that exploits untapped opportunities on a worldwide basis. This business model is designed to meet the needs of a complex healthcare ecosystem currently straining to contain costs while improving access to therapies. The company has an international base of operations to develop therapeutics better, faster and more inexpensively – in proximity to target markets. Naia’s operating structure includes a Cayman Island-based management company and several holding companies that focus on development activities of like assets. The company is developing a diverse portfolio of therapeutics that address regional and global unmet medical needs in various markets with an initial focus on rare and metabolic diseases. For more information, please visit www.naiapharma.com.

swizz
29/4/2015
14:16
The MM s knew this was coming hence the price post RNS
a2584728
29/4/2015
14:11
Yup I have it as a buy.
monkey puzzle
Chat Pages: Latest  206  205  204  203  202  201  200  199  198  197  196  195  Older

Your Recent History

Delayed Upgrade Clock